Publicacións en colaboración con investigadores/as de Universidad Europea de Madrid (34)

2024

  1. Critical review of the evidence for Vojta Therapy: a systematic review and meta-analysis

    Frontiers in Neurology , Vol. 15

  2. Outcomes of controlled DCDD lung transplantation after thoraco-abdominal vs abdominal normothermic regional perfusion: The Spanish experience

    Journal of Heart and Lung Transplantation

  3. Prognosis after heart transplant in patients with hypertrophic and restrictive cardiomyopathy. A nationwide registry analysis

    Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 304-313

  4. Repetitive ambulatory levosimendan as a bridge to heart transplantation

    Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 290-301

  5. Should we measure quality of life among people with HIV? A multicentre survey of physicians' opinions in Spain

    HIV Medicine

2023

  1. Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care

    Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269

  2. Changes in echocardiographic parameters over time in paradoxical low-flow low-gradient aortic stenosis

    European heart journal. Cardiovascular Imaging, Vol. 24, Núm. 8, pp. 1120-1128

  3. Conduction system pacing and atrioventricular node ablation in heart failure: The PACE-FIB study design

    ESC Heart Failure, Vol. 10, Núm. 6, pp. 3700-3709

  4. Hyperthermic Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: Results of the HIVEC-1 Trial

    European urology oncology, Vol. 6, Núm. 1, pp. 58-66

  5. Optical coherence tomography assessment of pulmonary vascular remodeling in advanced heart failure. The OCTOPUS-CHF study

    Revista Espanola de Cardiologia, Vol. 76, Núm. 5, pp. 312-321

  6. Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial

    The Lancet, Vol. 401, Núm. 10371, pp. 105-117

2022

  1. Challenging Endocrine Sensitivity of Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with the Combination of Eribulin and Endocrine Therapy: The REVERT Study

    Cancers, Vol. 14, Núm. 23

  2. Impact of intrapatient blood level variability of calcineurin inhibitors on heart transplant outcomes

    Revista Espanola de Cardiologia, Vol. 75, Núm. 2, pp. 129-140

  3. Pulmonary Vascular Remodeling and Prognosis in Patients Evaluated for Heart Transplantation: Insights from the OCTOPUS-CHF Study

    Journal of Cardiovascular Development and Disease, Vol. 9, Núm. 12

  4. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)

    European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301

  5. Results of heart retransplantation: subanalysis of the Spanish Heart Transplant Registry

    Revista Espanola de Cardiologia, Vol. 75, Núm. 1, pp. 60-66

2021

  1. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study

    HIV Medicine, Vol. 22, Núm. 9, pp. 867-876

  2. Impact of donor-recipient age on cardiac transplant survival. Subanalysis of the Spanish Heart Transplant Registry

    Revista Espanola de Cardiologia, Vol. 74, Núm. 5, pp. 393-401

2020

  1. Cold ischemia >4 hours increases heart transplantation mortality. An analysis of the Spanish heart transplantation registry

    International Journal of Cardiology, Vol. 319, pp. 14-19

  2. Development of an application for mobile phones (App) based on the collaboration between the Spanish Society of Rheumatology and Spanish Society of Family Medicine for the referral of systemic autoimmune diseases from primary care to rheumatology

    Reumatologia Clinica, Vol. 16, Núm. 5, pp. 373-377